Mpox (formerly named monkeypox) situation update, as of 6 … – European Centre for Disease

European Centre for Disease Prevention and Control
An agency of the European Union
Since the last update on 22 November 2022, and as of 6 December 2022, 36 mpox cases have been reported from 10 EU/EEA countries.
Since the last update on 22 November 2022, and as of 6 December 2022, 36 mpox cases have been reported from 10 EU/EEA countries.
Excluding data from the last three weeks, which may be incomplete, 41 cases were reported in week 45 (7–13 November 2022). This is a decline of 34.1% compared to week 44 (31 October–6 November 2022). 
Compared to the peak of reported cases (2 164 cases during week 29; 18–24 July 2022), there has been a decrease of 98.8% in the number of newly reported cases during week 44.
As of 6 December 2022, 17 countries have not reported an mpox case for more than 21 days.
Since the start of the mpox outbreak and as of 6 December 2022, 20 934 confirmed cases of mpox have been reported from 29 EU/EEA countries, and 62 cases have been reported from three Western Balkan countries and Türkiye.
According to the report published by the World Health Organization (WHO), the number of new mpox cases reported weekly have increased by 52.9% in week 48 (28 November–4 December 2022) compared to week 47 (21–27 November 2022). According to the report, globally, the majority of cases (93.7%) were reported in the Region of the Americas.
Based on the updated ECDC risk assessment, and the declining number of new infections, the overall risk of mpox infection is assessed as moderate for men who have sex with men (MSM) and low for the broader population.
Mpox continues to primarily affect MSM between 18 and 50 years of age. Mass gatherings and specific sexual practices are likely to have facilitated the transmission of mpox among this group.
The weekly number of mpox cases reported in the EU/EEA peaked in July 2022, and a steady declining trend has been observed since then. Multiple factors have probably contributed to the decline of this outbreak, including efforts in risk communication and community engagement, increasing immunity in the most affected population groups due to natural immunity and vaccination, and a decrease in the number of large cultural and social events frequented by the main risk groups for this outbreak after the summer.
Options for EU/EEA countries to respond to mpox cases include raising awareness of health professionals, supporting sexual health services to continue case detection, contact tracing, and management of cases; continuing to offer testing for orthopoxvirus; a vaccination strategy; and continuing risk communication and community engagement, despite the decreasing number of cases.
ECDC is closely monitoring the mpox epidemiological situation and will review the level of risk according to the evolution of the outbreak.  
Note: Data presented in this update are compiled from TESSy.
External Link
Weekly updates for the countries of the WHO European Region which includes additional analyses including on sexual orientation, clinical characteristics, hospitalisation and outcome. 

External Link
WHO report providing global overview of the mpox (monkeypox) epidemiological situation.
Source of information: WHO MPX Global epidemiological update
The mpox (monkeypox) virus is transmitted to humans through a bite or direct contact with an infected animal’s blood, body fluids or cutaneous/mucosal lesions.
What is mpox (monkeypox)? How does it spread? Learn more about the disease and the current outbreak.


Leave a Comment

%d bloggers like this: